Microglial Lag3 Drives α-Synuclein–induced Neurotoxic Activated (A1) Astrocytes and Neurodegeneration

This study identifies microglial Lag3 as a key receptor linking extracellular α-syn PFF recognition to inflammatory amplification, neurotoxic reactive A1 astrocyte conversion, and dopaminergic neurodegeneration. Together with prior work on neuronal Lag3, these findings support a cell-type-specific dual-axis model in which neuronal Lag3 mediates α-syn propagation while microglial Lag3 drives glia-dependent neurotoxicity, positioning Lag3 as a promising precision therapeutic target in α-synucleinopathies.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-01-06
DOI
https://doi.org/10.64898/2026.01.06.697996
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Microglial Lag3 Drives α-Synuclein–induced Neurotoxic Activated (A1) Astrocytes and Neurodegeneration

Ramhari Kumbhar, Sung-Ung Kang, Valina L. Dawson, Han Seok Ko et al.
bioRxiv (Cold Spring Harbor Laboratory)
Parkinson's Disease Mechanisms and Treatments
article

Microglial Lag3 Drives α-Synuclein–induced Neurotoxic Activated (A1) Astrocytes and Neurodegeneration

Ramhari Kumbhar, Sung-Ung Kang, Valina L. Dawson, Han Seok Ko, Enquan Xu, Xiaobo Mao, Yasuyoshi Kimura, S. -H. Li, Bo Am Seo, Mingyao Ying, Jared T. Hinkle, Nicolas Stanciu, Ning Wang, Xiuli Yang, F. C. Cheng, Ted Dawson, Haiqing Liu, Rong Chen, Lili Niu, Shinwon Ha
article en

Abstract

This study identifies microglial Lag3 as a key receptor linking extracellular α-syn PFF recognition to inflammatory amplification, neurotoxic reactive A1 astrocyte conversion, and dopaminergic neurodegeneration. Together with prior work on neuronal Lag3, these findings support a cell-type-specific dual-axis model in which neuronal Lag3 mediates α-syn propagation while microglial Lag3 drives glia-dependent neurotoxicity, positioning Lag3 as a promising precision therapeutic target in α-synucleinopathies.

bioRxiv (Cold Spring Harbor Laboratory)
Kennedy Krieger Institute (US), Johns Hopkins University (US), Johns Hopkins Medicine (US)
Robert J. and Claire Pasarow Foundation, Adrienne Helis Malvin Medical Research Foundation, Johns Hopkins University, National Institutes of Health, National Institute on Aging, National Institute of General Medical Sciences
Openalex Percentile: Top 93%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.